Enestnd 4-Year (y) Update: Continued Superiority of Nilotinib Vs Imatinib in Patients (pts) with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

被引：14

作者：

Kantarjian, Hagop M. ^{[1
]}

Kim, Dong-Wook ^{[2
]}

Issaragrisil, Surapol ^{[3
]}

Clark, Richard E. ^{[4
]}

Reiffers, Josy ^{[5
]}

Nicolini, Franck E. ^{[6
]}

Pasquini, Ricardo ^{[7
]}

Kalaycio, Matt ^{[8
]}

Hughes, Timothy P. ^{[9
]}

Hochhaus, Andreas ^{[10
]}

Kemp, Charisse ^{[11
]}

Fan, Xiaolin ^{[11
]}

Waltzman, Roger J. ^{[11
]}

Saglio, Giuseppe ^{[12
]}

Larson, Richard A. ^{[13
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[3] Siriraj Hosp, Fac Med, Dept Med, Div Hematol, Bangkok, Thailand

[4] Royal Liverpool Univ Hosp, Dept Haematol, Liverpool, Merseyside, England

[5] CRLCC Inst Bergonie, Bordeaux, France

[6] Hop Edouard Herriot, Lyon, France

[7] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil

[8] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA

[9] Royal Adelaide Hosp, Dept Haematol, SA Pathol, Adelaide, SA 5000, Australia

[10] Univ Klinikum Jena, Dept Hematol & Oncol, Jena, Germany

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Univ Turin, Div Internal Med & Hematol, Orbassano, Italy

[13] Univ Chicago, Chicago, IL 60637 USA

来源：

关键词：

D O I：

10.1182/blood.V120.21.1676.1676

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1676

引用

页数：3